Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01857193 |
|---|---|
| Brief Title: | Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer |
| First Submitted : | May 16, 2013 |
| First Submitted that Met QC Criteria : | May 16, 2013 |
| First Posted : | May 20, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 8, 2021 |
| Last Update Posted : | April 13, 2021 |